Self-Monitoring Blood Glucose (SMBG) Devices Market Report 2026

Self-Monitoring Blood Glucose (SMBG) Devices Market Overview

• Self-Monitoring Blood Glucose (SMBG) Devices market size has reached to $16.19 billion in 2025 • Expected to grow to $24.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Prevalence Of Diabetes Drives Self-Monitoring Blood Glucose Devices Market Growth • Market Trend: Sensor-Based Glucose Monitoring Devices Gaining Traction In The Market • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Self-Monitoring Blood Glucose (SMBG) Devices Market?

Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood. The main types of self-monitoring blood glucose (SMBG) devices are self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Self-monitoring blood glucose meters refer to handheld devices used by patients at home to check their blood glucose levels. Glucose meters usually require a drop of blood from the patient which is usually obtained from a pinprick. They are distributed by hospital pharmacies, retail pharmacies, online sales, and diabetes clinics & centers. These are used in various applications such as Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes.

What Is The Self-Monitoring Blood Glucose (SMBG) Devices Market Growth Forecast?

The self-monitoring blood glucose (smbg) devices market size is expected to see strong growth in the next few years. It will grow to $24.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for connected health solutions, rising adoption of continuous glucose monitoring, expansion of telehealth-based diabetes care, growing focus on preventive healthcare, increasing investments in digital diabetes management. Major trends in the forecast period include increasing adoption of smart glucose monitoring devices, rising use of continuous glucose monitoring systems, growing integration of mobile health applications, expansion of remote patient monitoring solutions, enhanced focus on patient-friendly device design.

What Is The Driver Of The Self-Monitoring Blood Glucose (SMBG) Devices Market?

The rising prevalence of diabetes is expected to propel the growth of the self-monitoring blood glucose device market going forward. Diabetes refers to a chronic metabolic disorder in which the body either does not produce enough insulin or cannot use it effectively, leading to elevated blood glucose levels that, over time, can damage various organs and systems. Rising prevalence of diabetes is primarily due to unhealthy dietary patterns that increase long-term blood sugar levels and gradually strain metabolic health over time. Self-Monitoring Blood Glucose (SMBG) Devices help diabetes by enabling individuals to track real-time blood sugar levels, allowing timely adjustments in diet, medication, or activity to maintain better glycemic control. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the rising prevalence of diabetes is driving the growth of the self-monitoring blood glucose devices market.

Key Players In The Global Self-Monitoring Blood Glucose (SMBG) Devices Market

Major companies operating in the self-monitoring blood glucose (smbg) devices market are Abbott Laboratories, Bionime Corporation, B Braun Melsungen AG, F Hoffmann La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Senseonics Holdings Inc, AgaMatrix Inc, All Medicus Co Ltd, Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Cnoga Medical Ltd, ForaCare Inc, Infopia Co Ltd, Menarini Diagnostics, Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc, OrSense Ltd, Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc

Global Self-Monitoring Blood Glucose (SMBG) Devices Market Trends and Insights

Major companies operating in the self-monitoring blood glucose (SMBG) devices market are focusing on developing innovative solutions, such as continuous glucose monitoring (CGM) systems, to meet the rising demand for less burdensome glucose tracking, improved glycemic control, remote patient monitoring, and better integration with insulin delivery and digital health platforms. CGM systems are wearable sensors that measure interstitial glucose continuously and provide trend data, alerts, and cloud-connected reporting; key features include real-time glucose readings, trend arrows, customizable alarms, and data sharing. Unlike traditional fingerstick SMBG (glucometers) that require discrete capillary blood samples and provide only point-in-time values, CGMs enable proactive therapy adjustments and richer longitudinal insights that reduce hypoglycemia risk and improve time-in-range. For instance, in August 2024, Medtronic plc, an Ireland-based medical technology company, launched Simplera CGM, a compact, disposable, all-in-one continuous glucose monitor designed for easier self-application, real-time glucose sensing, and seamless use with both the InPen smart insulin pen and the MiniMed 780G system, offering users a smaller form factor, simplified wear, and enhanced interoperability that supports continuous visibility for Smart MDI users, redundant sensing for pump users, and overall improved comfort, adherence, and clinical decision-making through continuous glucose trend data integration.

What Are Latest Mergers And Acquisitions In The Self-Monitoring Blood Glucose (SMBG) Devices Market?

In October 2025, OSR Holdings Inc., a US-based healthcare technology company, acquired Woori IO Co. Ltd. for an undisclosed amount. With this acquisition, OSR Holdings Inc. aims to strengthen its medical-device platform, diversify its healthcare portfolio, and capture recurring revenue in the global glucose-monitoring market via Woori IO’s breakthrough needle-free continuous glucose monitoring technology. Woori IO Co. Ltd. is a South Korea–based technology company that specializes in noninvasive glucose monitoring using its proprietary near-infrared spectroscopy (NIRS) biosensing system.

What Defines the Self-Monitoring Blood Glucose (SMBG) Devices Market?

The self-monitoring blood glucose (SMBG) device market consists of sales of devices and instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Self-Monitoring Blood Glucose (SMBG) Devices Market Report 2026?

The self-monitoring blood glucose (smbg) devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the self-monitoring blood glucose (smbg) devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.